#AskDrDurie

Learn about the latest myeloma research. Get a front row seat at the most critical medical meetings. Watch Dr. Brian Durie, IMF Chairman, address issues that are important to the entire myeloma community. IMF TV brings it all to you.

May
25
What exactly is high-risk myeloma and how should it be treated?
In this week’s video, Dr. Brian Durie discusses why the ideal therapy for high-risk myeloma is still unknown, but presents options for treatment. BOTTOM LINE: ​ Because of the different types of high(...)
May
18
If my myeloma is in remission and my IgG myeloma protein has spiked, why is my doctor not recommending any new treatment?
In this week’s video, Dr. Brian GM Durie explains two treatment approaches if you are in remission and your myeloma protein spikes.
May
11
Does using daratumumab make response-monitoring difficult?
In this week’s video, Dr. Brian Durie explains how daratumumab may interfere with response-monitoring and with blood transfusions for myeloma patients. BOTTOM LINE: ​ If you are taking dara, discuss(...)
May
04
Can myeloma cells be detected in the blood instead of the bone marrow?
In this week’s video, Dr. Brian Durie sheds light on advances in testing for myeloma cells in the blood. The BOTTOM LINE: Using blood instead of bone marrow to test for myeloma cells may become(...)
Apr
27
How do the new guidelines on X-rays and scans affect my testing and monitoring?
In this week’s video, Dr. Brian Durie explains the best uses for whole-body, low-dose CT scans as well as MRIs for myeloma patients. BOTTOM LINE: Discuss which types of scans and X-rays will be used(...)
Apr
20
What is the role of high-dose melphalan with autologous stem cell transplant (ASCT) in 2017?
In this week’s video, Dr. Brian Durie discusses the value of ASCT even with the use of newer drug regimens. BOTTOM LINE: ​ We still value high-dose melphalan with ASCT in 2017. Have a question?(...)